Existing data suggest that the use of any of them, even those classified under category B, must be weighed against the potential short- and long-term risk for the fetus.
El manejo integral de las patologías que pudieran generar dolor durante el embarazo requiere del uso de medicamentos que no siempre son 100% seguros.